BlueCrest Capital Management Ltd - ENDOLOGIX INC ownership

ENDOLOGIX INC's ticker is ELGX and the CUSIP is 29266S106. A total of 140 filers reported holding ENDOLOGIX INC in Q1 2016. The put-call ratio across all filers is 5.07 and the average weighting 0.3%.

Quarter-by-quarter ownership
BlueCrest Capital Management Ltd ownership history of ENDOLOGIX INC
ValueSharesWeighting
Q3 2018$209,000
+254.2%
109,219
+945.8%
0.01%
+200.0%
Q2 2018$59,000
-85.9%
10,444
-89.4%
0.00%
-84.6%
Q1 2018$417,000
+384.9%
98,687
+459.9%
0.01%
+333.3%
Q2 2017$86,000
-25.2%
17,626
+51.9%
0.00%
-40.0%
Q4 2015$115,00011,6000.01%
Other shareholders
ENDOLOGIX INC shareholders Q1 2016
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 1,121,447$2,142,0001.45%
Essex Woodlands Management, Inc. 1,257,468$6,684,0001.39%
Camber Capital Management LP 9,300,000$17,763,0000.76%
PFM Health Sciences, LP 7,408,585$14,150,0000.21%
NEA Management Company, LLC 2,490,204$4,756,0000.20%
ArrowMark Colorado Holdings LLC 10,276,145$19,627,0000.16%
Brown Capital Management 8,977,308$17,147,0000.16%
Partner Investment Management, L.P. 79,765$152,0000.12%
ALTRINSIC GLOBAL ADVISORS LLC 1,135,000$2,168,0000.10%
Lombard Odier Asset Management (USA) Corp 700,000$1,337,0000.10%
View complete list of ENDOLOGIX INC shareholders